儿科药学杂志2018，Vol.24Issue(1)：34-37,4.DOI:10.13407/j.cnki.jpp.1672-108X.2018.01.012
《WHO儿童基本药物标准清单(第6版)》对制定我国儿童基本药物目录的参考性分析——基于34家儿童专科医院调研结果
Analysis the Reference of WHO Model List of Essential Medicines for Children (6th list) to Essential Medicines for Children of China——Based on 34 Children's Hospitals
张萌 1陈哲 2郭春彦 1谢晓慧 3周瑞瑞 3王晓玲1
作者信息
- 1. 首都医科大学附属北京儿童医院,北京100045
- 2. 郑州大学第一附属医院,河南郑州450003
- 3. 北京大学药学院,北京100191
- 折叠
摘要
Abstract
Objective:Comparaing WHO Model List of Essential Medicines for Children (6th list) (EMLc) to medicines used in pediatric clinical,to provide reference of developing essential medicine list for children in China.Methods:Active ingredients in common use of 34 Children's Hospitals were investigated,compared the results to 6th EMLc and National Essential Medicine List (2012 edition).Results:There are 327 active ingredients in common use in Chinese pediatric clinical.Ninety-six of them exist in both 6th EMLc and National Essential Medicine List (2012 edition) and 28 of them exist only in 6th EMLc.There are some differences in the proportions of different clinical action categories of medicines in these three lists.Conclusion:Some of medicines exist in 6th EMLc should be considered included in our essential medicine list for children,while the clinical action categories and proportion should be fully considered based on national conditions and characteristics of pediatrics.关键词
儿童/WHO儿童基本药物标准清单/基本药物Key words
children/WHO Model List of Essential Medicines for Children/essential medicine分类
医药卫生引用本文复制引用
张萌,陈哲,郭春彦,谢晓慧,周瑞瑞,王晓玲..《WHO儿童基本药物标准清单(第6版)》对制定我国儿童基本药物目录的参考性分析——基于34家儿童专科医院调研结果[J].儿科药学杂志,2018,24(1):34-37,4.
